Omalizumab for Aspirin Hypersensitivity and Leukotriene Overproduction in Aspirin-exacerbated Respiratory Disease. A Randomized Controlled Trial

Rationale: Aspirin-exacerbated respiratory disease is characterized by severe asthma, nonsteroidal antiinflammatory drug hypersensitivity, nasal polyposis, and leukotriene overproduction. Systemic corticosteroid therapy does not completely suppress lifelong aspirin hypersensitivity. Omalizumab effic...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Am J Respir Crit Care Med
Autors principals: Hayashi, Hiroaki, Fukutomi, Yuma, Mitsui, Chihiro, Kajiwara, Keiichi, Watai, Kentaro, Kamide, Yosuke, Nakamura, Yuto, Hamada, Yuto, Tomita, Yasuhiro, Sekiya, Kiyoshi, Tsuburai, Takahiro, Izuhara, Kenji, Wakahara, Keiko, Hashimoto, Naozumi, Hasegawa, Yoshinori, Taniguchi, Masami
Format: Artigo
Idioma:Inglês
Publicat: American Thoracic Society 2020
Matèries:
Original Articles
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7301746/
https://ncbi.nlm.nih.gov/pubmed/32142372
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1164/rccm.201906-1215OC
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars